Advances and Prospects in Vaccine Development against Enterococci
Enterococci are the second most common Gram-positive pathogen responsible for nosocomial infections. Due to the limited number of new antibiotics that reach the medical practice and the resistance of enterococci to the current antibiotic options, passive and active immunotherapies have emerged as a...
Main Authors: | Ermioni Kalfopoulou, Johannes Huebner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/11/2397 |
Similar Items
-
Peptide/β-Peptoid Hybrids with Activity against Vancomycin-Resistant Enterococci: Influence of Hydrophobicity and Structural Features on Antibacterial and Hemolytic Properties
by: Martin Vestergaard, et al.
Published: (2021-05-01) -
Risk factors for intestinal colonization with vancomycin resistant enterococci’ A prospective study in a level III pediatric intensive care unit
by: Rajesh Amberpet, et al.
Published: (2018-01-01) -
Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda
by: David P. Kateete, et al.
Published: (2019-05-01) -
The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections
by: Olaniyi Ayobami, et al.
Published: (2020-01-01) -
Fecal Colonization with Vancomycin-Resistant Enterococci in Australia
by: Alexander A. Padiglione, et al.
Published: (2000-10-01)